Clinical trial
Biological Therapy in Treating Patients With Advanced Cancer
NCT00005956 · Duke University, Other · Completed
Key facts
| NCT number | NCT00005956 |
|---|---|
| Title | Biological Therapy in Treating Patients With Advanced Cancer |
| Official title | A Pilot Study of Active Immunotherapy With HER2/Neu Intracellular Domain (ICD) Protein-Pulsed, Autologous, Cultured Dendritic Cells in Patients With No Evidence of Disease After Standard Treatment for HER2/Neu Expressing Malignancies |
| Lead sponsor | Duke University, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Study type | Interventional |
| Conditions | Breast Cancer, Gastric Cancer, Ovarian Cancer |
| Intervention type | Biological |
| Interventions | HER-2/neu intracellular domain protein, therapeutic autologous dendritic cells |
| Enrollment | 3 |
| Start date | Feb 1, 2000 |
| Primary completion | Aug 1, 2001 |
| Completion | Jul 1, 2002 |
| First posted | May 21, 2003 |
| Last update posted | Jul 9, 2014 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: